The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

9 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Novel inhibitors targeting PPM1D phosphatase potently suppress cancer cell proliferation.EBI
Hokkaido University
Targeting the PPM1D phenotype; 2,4-bisarylthiazoles cause highly selective apoptosis in PPM1D amplified cell-lines.EBI
The Institute of Cancer Research
Structurally diverse low molecular weight activators of the mammalian pre-mRNA 3' cleavage reaction.EBI
The City University of New York
A small molecule inhibitor of p53-inducible protein phosphatase PPM1D.EBI
Hokkaido University
Screening Ultra-Large Encoded Compound Libraries Leads to Novel Protein-Ligand Interactions and High Selectivity.EBI
Astrazeneca
Alkyl-substituted N-methylaryl-N'-aryl-4-aminobenzamides: A new series of small molecule inhibitors for Wip1 phosphatase.EBI
Niddk
Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application.EBI
China Pharmaceutical University
Chemical Space of DNA-Encoded Libraries.EBI
University of Utah
Heterocycles as WIP1 InhibitorsBDB
PMV Pharmaceuticals, Inc.